MaxCyte (MXCT) (MXCT)
:MXCT
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 33.03M | $ 38.63M | $ 41.29M | $ 44.26M | $ 33.89M |
| Gross Profit | $ 26.80M | $ 31.53M | $ 36.55M | $ 39.16M | $ 30.25M |
| Operating Income | $ -43.55M | $ -51.20M | $ -48.30M | $ -27.36M | $ -18.19M |
| EBITDA | $ -40.14M | $ -46.41M | $ -44.13M | $ -24.66M | $ -16.61M |
| Net Income | $ -44.63M | $ -41.05M | $ -37.92M | $ -23.57M | $ -19.08M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 103.04M | $ 154.48M | $ 168.29M | $ 227.34M | $ 255.04M |
| Total Assets | $ 202.51M | $ 239.47M | $ 268.27M | $ 286.65M | $ 284.12M |
| Total Debt | $ 17.94M | $ 18.03M | $ 18.74M | $ 16.09M | $ 5.68M |
| Net Debt | $ -2.12M | $ -9.85M | $ -27.76M | $ 5.03M | $ -42.10M |
| Total Liabilities | $ 31.02M | $ 33.22M | $ 36.11M | $ 32.69M | $ 21.22M |
| Stockholders' Equity | $ 171.49M | $ 206.25M | $ 232.17M | $ 253.97M | $ 262.90M |
| Cash Flow | |||||
| Free Cash Flow | $ -36.18M | $ -29.26M | $ -25.39M | $ -33.26M | $ -14.51M |
| Operating Cash Flow | $ -34.41M | $ -27.61M | $ -21.69M | $ -14.78M | $ -10.68M |
| Investing Cash Flow | $ 25.93M | $ 6.93M | $ 54.98M | $ -24.82M | $ -195.01M |
| Financing Cash Flow | $ 656.00K | $ 2.06M | $ 2.14M | $ 2.89M | $ 234.72M |
MaxCyte Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.